Friday, October 7, 2016

Billions at stake as Bristol-Myers waits its chance to redeem its lung cancer drug

… , Opdivo, failed in a large lung cancer trial in August, investors wiped … implications for how we treat lung cancer, the leading cause of cancer … cancer, blood cancer, and in lung cancer for which patients had already … treatment of advanced non-small cell lung cancer, a market opportunity SunTrust analyst …

No comments:

Post a Comment